Recent CDC FluView surveillance data through mid-May 2026 shows the 2025–26 influenza season’s cumulative hospitalization rate stabilizing near 85–90 per 100,000 population, driven by moderate winter peaks followed by sharp post-peak declines in new admissions. Official weekly reports confirm minimal ongoing transmission consistent with historical patterns for Week 19, when activity typically falls below epidemic thresholds. Traders have converged on this narrow range because model projections and preliminary end-of-season totals align closely with observed case trajectories, leaving limited scope for substantial upward or downward revisions before final reporting. A late-season resurgence or significant retroactive adjustments to hospitalization counts remain the only realistic scenarios that could shift the outcome outside 85–90.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourFlu Hospitalization Rate Week 19, 2026?
Flu Hospitalization Rate Week 19, 2026?
85–90 96.0%
80–85 1.0%
<80 <1%
95–100 <1%
NOUVEAU
NOUVEAU
22 mai 2026
<80
1%
80–85
1%
85–90
96%
90–95
<1%
95–100
1%
100+
1%
85–90 96.0%
80–85 1.0%
<80 <1%
95–100 <1%
NOUVEAU
NOUVEAU
22 mai 2026
<80
$758 Vol.
1%
80–85
$2,258 Vol.
1%
85–90
$1,135 Vol.
96%
90–95
$340 Vol.
<1%
95–100
$465 Vol.
1%
100+
$381 Vol.
1%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluView surveillance data through mid-May 2026 shows the 2025–26 influenza season’s cumulative hospitalization rate stabilizing near 85–90 per 100,000 population, driven by moderate winter peaks followed by sharp post-peak declines in new admissions. Official weekly reports confirm minimal ongoing transmission consistent with historical patterns for Week 19, when activity typically falls below epidemic thresholds. Traders have converged on this narrow range because model projections and preliminary end-of-season totals align closely with observed case trajectories, leaving limited scope for substantial upward or downward revisions before final reporting. A late-season resurgence or significant retroactive adjustments to hospitalization counts remain the only realistic scenarios that could shift the outcome outside 85–90.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Marché ouvert : May 14, 2026, 7:51 PM ET
Volume
$5,338Date de fin
22 mai 2026Marché ouvert
May 14, 2026, 7:51 PM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluView surveillance data through mid-May 2026 shows the 2025–26 influenza season’s cumulative hospitalization rate stabilizing near 85–90 per 100,000 population, driven by moderate winter peaks followed by sharp post-peak declines in new admissions. Official weekly reports confirm minimal ongoing transmission consistent with historical patterns for Week 19, when activity typically falls below epidemic thresholds. Traders have converged on this narrow range because model projections and preliminary end-of-season totals align closely with observed case trajectories, leaving limited scope for substantial upward or downward revisions before final reporting. A late-season resurgence or significant retroactive adjustments to hospitalization counts remain the only realistic scenarios that could shift the outcome outside 85–90.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$5,338Date de fin
22 mai 2026Marché ouvert
May 14, 2026, 7:51 PM ETResolver
0x69c47De9D...Recent CDC FluView surveillance data through mid-May 2026 shows the 2025–26 influenza season’s cumulative hospitalization rate stabilizing near 85–90 per 100,000 population, driven by moderate winter peaks followed by sharp post-peak declines in new admissions. Official weekly reports confirm minimal ongoing transmission consistent with historical patterns for Week 19, when activity typically falls below epidemic thresholds. Traders have converged on this narrow range because model projections and preliminary end-of-season totals align closely with observed case trajectories, leaving limited scope for substantial upward or downward revisions before final reporting. A late-season resurgence or significant retroactive adjustments to hospitalization counts remain the only realistic scenarios that could shift the outcome outside 85–90.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes